The assessment of hepatic function by breath analysis after the oral administration of (dimethylamine-14C)-aminopyrine has been described by two groups (Hepner and Vesell, 1975; Bircher et al., 1976a; Lauterburg and Bircher, 1976) . The test is based on the fact that aminopyrine is metabolised primarily in the liver with conversion of the 14C-labelled methyl groups to 14CO2 and that the concentration of 14CO2 in the breath is related to the rate of aminopyrine metabolism (Hepner and Vesell, 1974; Bircher et al., 1976b) . It involves the oral administration of a trace dose of 14C-labelled aminopyrine and collection of a breath sample for analysis at two hours (Hepner and Vesell, 1975) . Hepner found a highly significant correlation between the two-hour 14CO2 output and the aminopyrine metabolic clearance rate in control subjects and cirrhotic patients (Hepner and Vesell, 1974 (Hepner and Vesell, 1975) An oral dose of 1-5 ,uCi (dimethylamine-14C)-aminopyrine (Amersham, specific activity 12-2 mCi/ mmol, 98 % radiochemically pure) was given in water without previous fasting, and the subject was asked to rest quietly. Two hours later breath was collected by blowing through 4 ml M hyamine hydroxide-ethanol in a glass scintillation vial until the thymol-phthalein indicator showed a sudden colour change from blue to colourless. This indicated that 2 mmol C02 had been collected. After addition of scintillation cocktail the 14CO2 was counted and specific activity calculated. The cumulative excretion in the two-hour period was calculated by multiplying the specific activity by the endogenous output of carbon dioxide (ie, 9 mmol kg-' h-1 (Winchell et al., 1970) The mean 14CO2 excretion of the 16 patients with cirrhosis (5 1 ± 3 8 %) was significantly lower than that (8 6 ± 1=5 %) of the control group (p > 0 01) despite four cirrhotics who had values in the high normal range; these were the patients taking enzymeinducing drugs. Four out of five patients with 14CO2 excretion below 2 5 % died during the eight months of the study. The scatter of 14CO2 excretion in 20 alcoholics without permanent liver damage was very wide but the mean value of 10-6 + 2=6% was significantly above the mean control value (P < 0 05).
The mean figures for C02 excretion in patients taking barbiturates, corticosteroids, and opiates were respectively 15-2 ± 4=0%, 11-6 ± 1=4%, and 10 1 ± 2-0%. These were significantly different from normal at levels of P < 0=001, p < 0=01, and p < 0=05 respectively.
There was a significant correlation between 14CO2 excretion and serum y-GT in patients taking barbiturates ( Fig. 3) Cirrhotic patients had raised serum alkaline phosphatase levels (mean 292 ± 219 IU/l) and greatlyraisedy-GT(mean283 ± 2531U/I),andthere was no correlation between y-GT and 14CO2 excretion.
14CO2 excretion did not correlate with serum y-GT in the non-cirrhotic alcoholic patients. When the four patients with alkaline phosphatase greater than 120 IU/I were excluded the mean values for alkaline phosphatase and y-GT were 78 ± 19 and 139 ± 85 IU/I respectively, and there was a significant correlation between 14CO2 excretion and y-GT (r = 0-50, p < 0-05).
Discussion
We have confirmed that, in general, patients with cirrhosis have a reduced 14CO2 excretion after 14C-aminopyrine administration. Moreover, the test may have some prognostic value, since the lowest values were found in patients who died of liver failure during the course of the study. It is cheap, easy to perform, non-invasive, and acceptable to patients. The dose of radiation is 0-5-2-5 mrem (comparable to a routine diagnostic chest radiograph), and repeated tests can be done in the same patient.
We had expected to find values intermediate between the normal and the cirrhotic groups (Hepner and Vesell, 1975) in alcoholics without permanent liver damage. Such patients, however, often had increased 14CO2 excretion and this correlated with the serum y-GT level in those patients with normal serum alkaline phosphatase. Exclusion of the patients with raised total alkaline phosphatase removes those with an obstructive cause for a raised y-GT (Ceriotti, 1976) but may not remove all such cases, for Brohult and Sundblad (1973) have demonstrated cholestasis in alcoholics with normal total alkaline phosphatase by the presence of alpha-I phosphatase isoenzyme in their serum. Prolonged consumption of alcohol increases hepatic mixedfunction oxidase activity (Lieber, 1973) , shortens the half-life of several drugs (Misra et al., 1971) , and raises the serum y-GT level even when other liver function tests are normal (Rosalki and Rau, 1972) . It has been suggested (Rosalki, 1975) that the sensitivity of serum y-GT to heavy alcohol consumption is in part due to y-GT induction in the hepatic microsomes and also to hepatic microsomal injury by alcohol. The significant correlation between the breath test and serum y-GT in patients taking barbiturates, which are known to cause up to three-fold increases in y-GT, suggests that the increase in breath test values is due to enzyme induction, and this may also be the explanation for the findings in alcoholics without permanent liver damage.
Although several methods exist for the measurement of enzyme induction, none is entirely satisfactory (Neale, 1975) . Nevertheless, we believe that the high 14CO2 excretion found in some of the patients may provide a pointer to enzyme induction. It is of considerable interest that the four patients with cirrhosis who had high values for 14CO2 excretion were all taking enzyme-inducing drugs, and this suggests that the diseased liver may still be capable of increasing its rate of drug metabolism (Levi et al., 1968) .
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